Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Medline Inc.

Medline Inc. (MDLN) Stock Overview

Explore Medline Inc.’s financial performance, market position, analyst ratings, and future outlook.

MDLN●NASDAQ
HealthcareMedical - Instruments & Supplies
$32.58
$1.33(3.92%)
U.S. Market opens in 15h 39m

Medline Inc. (MDLN)

Meyka AI Score

Z

Key Financials

Market Cap27.5B
P/E Ratio39.50
EPS (TTM)$1.36
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$-2.12
3 Months$40.44
1 Year Target$30.88

MDLN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Medline Inc. (NASDAQ: MDLN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Medline Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MDLN on the NASDAQ shows an RSI of 35.04, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $30.88 for the NASDAQ listing.

Key metrics behind Medline Inc.'s NASDAQ-traded stock include a P/E ratio of 39.50 and a market capitalization of 27.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MDLN on the NASDAQ.

Price Performance (NASDAQ: MDLN)

1-Day Change
-3.92%
5-Day Change
-8.43%
1-Month Change
-16.20%
3-Month Change
-10.12%
6-Month Change
-34.58%
Year-to-Date (YTD) Change
-22.43%
1-Year Change
-20.54%
3-Year Change
-20.54%
5-Year Change
-20.54%
All-Time (Max) Change
-20.54%

Contact Information

https://www.medline.com
(847) 949-5500
3 Lakes Drive, Northfield, IL, 60093

Company Facts

450,000 Employees
IPO DateDec 17, 2025
CountryUS
Actively Trading

Frequently Asked Questions